Cargando…

GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation

PURPOSE: This study aimed to retrospectively evaluate the genetic association of null variants of glutathione S-transferases GSTM1 and GSTT1 with relapse incidence in children with hematological malignancies (HMs) undergoing busulfan (BU)- containing allogeneic hematopoietic stem cell transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurkovic Mlakar, Simona, Uppugunduri, Satyanarayana Chakradhara Rao, Nava, Tiago, Mlakar, Vid, Golay, Hadrien, Robin, Shannon, Waespe, Nicolas, Rezgui, Mohamed Aziz, Chalandon, Yves, Boelens, Jaap Jan, Bredius, Robert G. M., Dalle, Jean-Hugues, Peters, Christina, Corbacioglu, Selim, Bittencourt, Henrique, Krajinovic, Maja, Ansari, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752561/ https://www.ncbi.nlm.nih.gov/pubmed/34499222 http://dx.doi.org/10.1007/s00432-021-03769-2

Ejemplares similares

Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
por: Jurkovic Mlakar, Simona, et al.
Publicado: (2021)

Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
por: Uppugunduri, C. R. S., et al.
Publicado: (2021)

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: Uppugunduri, Chakradhara Rao S., et al.
Publicado: (2017)

The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review
por: Golay, Hadrien, et al.
Publicado: (2019)

Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use †
por: Mlakar, Vid, et al.
Publicado: (2016)

Opposite Effects of GSTM1 – and GSTT1 – Gene Deletion Variants on Bone Mineral Density
por: Mlakar, Simona Jurkovic, et al.
Publicado: (2011)

A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome
por: Waespe, Nicolas, et al.
Publicado: (2023)

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study
por: Ansari, Marc, et al.
Publicado: (2017)

The influence of GSTT/GSTM null genotypes in scarring
por: Ilieş, Roxana Flavia, et al.
Publicado: (2019)

A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

Correction to: A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

Genetic Predictors for Sinusoidal Obstruction Syndrome—A Systematic Review
por: Waespe, Nicolas, et al.
Publicado: (2021)

GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs
por: Budai, Barna, et al.
Publicado: (2020)

Association of GSTM1 and GSTT1 Null Genotypes with Toluene Diisocyanate-Induced Asthma
por: Lee, Jong-Uk, et al.
Publicado: (2022)

Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy
por: Dadbinpour, Alamdar, et al.
Publicado: (2013)

A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
por: Mlakar, Vid, et al.
Publicado: (2021)

ADRA2A is involved in neuro-endocrine regulation of bone resorption
por: Mlakar, Vid, et al.
Publicado: (2015)

Null Genotypes of GSTM1 and GSTT1 Contribute to Risk of Cervical Neoplasia: An Evidence-Based Meta-Analysis
por: Gao, Lin-Bo, et al.
Publicado: (2011)

No contribution of GSTM1 and GSTT1 null genotypes to the risk of neutropenia due to benzene exposure in Southeastern Brazil
por: Lima, Carmen Silvia Passos, et al.
Publicado: (2009)

Combined GSTM1 and GSTT1 null genotypes are strong risk factors for atherogenesis in a Serbian population
por: Grubisa, Ivana, et al.
Publicado: (2018)

GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies
por: Li, Shanli, et al.
Publicado: (2019)

The Leucocyte Telomere Length, GSTM1 and GSTT1 Null Genotypes and the Risk of Chronic Obstructive Pulmonary Disease
por: Tacheva, Tanya, et al.
Publicado: (2022)

Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia
por: Abdalhabib, Ezeldine K, et al.
Publicado: (2021)

Null Genotypes of GSTM1 and GSTT1 and Endometriosis Risk: A Meta-Analysis of 25 Case-Control Studies
por: Zhu, Haili, et al.
Publicado: (2014)

Prevalence of Null Genotypes of Glutathione S-Transferase T1 (GSTT1) and M1 (GSTM1) in Seven Iranian Populations
por: NASSERI, Gholamreza, et al.
Publicado: (2015)

GSTT1 and GSTM1 null variants in Mestizo and Amerindian populations from northwestern Mexico and a literature review
por: Palma-Cano, Luz Elena, et al.
Publicado: (2017)

GSTM1 and GSTT1 null polymorphisms and male infertility risk: an updated meta-analysis encompassing 6934 subjects
por: Wu, Wei, et al.
Publicado: (2013)

Cancer Risk and GSTM1 and GSTT1 Polymorphisms
por: Cetta, Francesco, et al.
Publicado: (2009)

11q deletion in neuroblastoma: a review of biological and clinical implications
por: Mlakar, Vid, et al.
Publicado: (2017)

Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
por: Ben Hassine, Khalil, et al.
Publicado: (2021)

GSTM1 and GSTT1 Null Polymorphisms and Childhood Acute Leukemia Risk: Evidence from 26 Case-Control Studies
por: Tang, Qiuqin, et al.
Publicado: (2013)

CORRIGENDUM: GSTM1 and GSTT1 null polymorphisms and male infertility risk: an updated meta-analysis encompassing 6934 subjects
por: Wu, Wei, et al.
Publicado: (2013)

Glutathione S-Transferase M1 (GSTM1) and T1 (GSTT1) Null Polymorphisms and the Risk of Hypertension: A Meta-Analysis
por: Ge, Beihai, et al.
Publicado: (2015)

Frequencies of glutathione s-transferase (GSTM1, GSTM3 AND GSTT1) polymorphisms in a Malaysian population
por: Alshagga, Mustafa A., et al.
Publicado: (2011)

PRIMA-1(MET)-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level
por: Mlakar, Vid, et al.
Publicado: (2019)

GSTM1, GSTM3 and GSTT1 Gene Variants and Risk of Benign Prostate Hyperplasia in North India
por: Mittal, Rama Devi, et al.
Publicado: (2009)

GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population
por: Cho, Hyun-Jung, et al.
Publicado: (2005)

Associations between null mutations in GSTT1 and GSTM1, the GSTP1 Ile(105)Val polymorphism, and mortality in breast cancer survivors
por: Duggan, Catherine, et al.
Publicado: (2013)

GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients
por: Pinheiro, Denise S., et al.
Publicado: (2017)

The analysis of GSTA1 promoter genetic and functional diversity of human populations
por: Mlakar, Vid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oelfgdvdjg3dd43hpi82u9j46o